Patent · US Active

Method for breast cancer recurrence prediction under endocrine treatment

US10851427B2 · kind B2 · utility

0Cited by

0References

41Claims

0Family size

Assignee

MYRIAD INTERNATIONAL GMBH · DE

Inventors

Mareike Dartmann · Cologne, DE
Inke Sabine Feder · Leverkusen, DE
Mathias Gehrmann · Tönisvorst, DE
Guido Hennig · Wynau, CH
Karsten Weber · Leutenbach, DE
Christian Von Törne · Cologne, DE
Ralf Kronenwett · Cologne, DE
Christoph Petry · Cologne, DE

Key dates

Filing date	Jan 17, 2020
Grant date	Dec 1, 2020
Priority date	—
Expiry date	Jan 17, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/158
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention relates to methods, kits and systems for the prognosis of the disease outcome of breast cancer, said method comprising:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.